Back to tickers

Evoke Pharma Inc (EVOK)

Nasdaq · CIK 0001403708

Form Report Date Filing Date Description
8-K 2025-12-17 2025-12-17 8-K
8-K 2025-11-13 2025-11-13 8-K
10-Q 2025-09-30 2025-11-13 10-Q
8-K 2025-10-29 2025-11-04 8-K
8-K 2025-08-14 2025-08-14 8-K
10-Q 2025-06-30 2025-08-14 10-Q
8-K 2025-08-06 2025-08-06 8-K
8-K 2025-07-09 2025-07-09 8-K
8-K 2025-05-21 2025-05-22 8-K
10-Q 2025-03-31 2025-05-13 10-Q
8-K 2025-05-13 2025-05-13 8-K
10-K 2024-12-31 2025-03-13 10-K
8-K 2025-03-13 2025-03-13 8-K
8-K 2025-02-20 2025-02-24 8-K
8-K 2024-11-07 2024-11-07 8-K
10-Q 2024-09-30 2024-11-07 10-Q
8-K 2024-10-28 2024-10-28 8-K
8-K 2024-10-18 2024-10-22 8-K
8-K 2024-10-16 2024-10-17 8-K
8-K 2024-09-27 2024-09-27 8-K
8-K 2024-08-15 2024-08-16 8-K
8-K 2024-08-13 2024-08-13 8-K
10-Q 2024-06-30 2024-08-13 10-Q
8-K 2024-07-31 2024-08-01 8-K
8-K 2024-06-20 2024-06-20 8-K
8-K 2024-06-04 2024-06-07 8-K
8-K 2024-05-22 2024-05-28 8-K
10-Q 2024-03-31 2024-05-14 10-Q
8-K 2024-05-14 2024-05-14 8-K
8-K 2024-05-13 2024-05-14 8-K
8-K 2024-03-25 2024-03-25 8-K
8-K 2024-03-20 2024-03-21 8-K
8-K 2024-03-18 2024-03-18 8-K
10-K 2023-12-31 2024-03-14 10-K
8-K 2024-03-14 2024-03-14 8-K
8-K 2024-02-21 2024-02-23 8-K
8-K 2024-02-13 2024-02-14 8-K
8-K 2024-02-08 2024-02-09 8-K
8-K 2023-11-27 2023-11-29 8-K
8-K 2023-11-27 2023-11-27 8-K
8-K 2023-11-21 2023-11-22 8-K
10-Q 2023-09-30 2023-11-09 10-Q
8-K 2023-11-09 2023-11-09 8-K
8-K 2023-10-31 2023-11-01 8-K
8-K 2023-10-09 2023-10-12 8-K
8-K 2023-08-10 2023-08-10 8-K
10-Q 2023-06-30 2023-08-10 10-Q
8-K 2023-07-19 2023-07-21 8-K
8-K 2023-05-24 2023-05-26 8-K
8-K 2023-05-15 2023-05-15 8-K
10-Q 2023-03-31 2023-05-15 10-Q
8-K 2023-05-10 2023-05-11 8-K
8-K 2023-05-09 2023-05-09 8-K
8-K 2023-05-01 2023-05-01 8-K
8-K 2023-04-20 2023-04-20 8-K
8-K 2023-04-06 2023-04-06 8-K
8-K 2023-03-23 2023-03-23 8-K
10-K 2022-12-31 2023-03-21 10-K
8-K 2023-03-21 2023-03-21 8-K
8-K 2023-02-21 2023-02-21 8-K
8-K 2023-02-08 2023-02-13 8-K
8-K 2023-01-30 2023-01-30 8-K
8-K 2022-11-30 2022-11-30 8-K
10-Q 2022-09-30 2022-11-09 10-Q
8-K 2022-11-09 2022-11-09 8-K
8-K 2022-09-20 2022-09-20 8-K
8-K 2022-08-24 2022-08-26 8-K
8-K 2022-08-10 2022-08-10 8-K
10-Q 2022-06-30 2022-08-10 10-Q
8-K 2022-06-07 2022-06-08 8-K
8-K 2022-05-23 2022-05-23 8-K
8-K 2022-05-19 2022-05-20 8-K
8-K 2022-05-10 2022-05-10 8-K Q1 EARNINGS RELEASE
10-Q 2022-03-31 2022-05-10 10-Q
8-K 2022-04-27 2022-04-28 8-K
8-K 2022-04-26 2022-04-26 8-K
10-K 2021-12-31 2022-03-08 10-K
8-K 2022-03-08 2022-03-08 8-K
8-K 2022-02-24 2022-02-24 8-K
8-K 2022-02-17 2022-02-17 8-K
8-K 2022-02-01 2022-02-02 8-K 02.01.22
8-K 2022-01-04 2022-01-04 8-K
8-K 2021-12-29 2021-12-30 8-K
10-Q 2021-09-30 2021-11-10 10-Q
8-K 2021-09-30 2021-11-10 8-K
8-K 2021-10-20 2021-10-20 8-K
8-K 2021-09-29 2021-09-29 8-K
10-Q 2021-06-30 2021-08-12 10-Q
8-K 2021-08-12 2021-08-12 8-K
8-K 2021-08-02 2021-08-02 8-K
8-K 2021-07-14 2021-07-14 8-K
8-K 2021-06-29 2021-06-29 8-K
8-K 2021-06-15 2021-06-15 8-K
8-K 2021-06-08 2021-06-08 8-K - PATENT-ORANGE BOOK APPROVAL
8-K 2021-06-02 2021-06-02 8-K - PATENT-ORANGE BOOK
8-K 2021-05-13 2021-05-14 8-K - REED APPOINTMENT
8-K 2021-05-12 2021-05-12 8-K - Q12021
10-Q 2021-03-31 2021-05-12 10-Q
8-K 2021-05-05 2021-05-06 8-K - 2021 ANNUAL MEETING
8-K 2021-04-06 2021-04-06 8-K - USPTO ORANGE BOOK
8-K 2021-03-11 2021-03-11 8-K - 4Q2020
10-K 2020-12-31 2021-03-11 10-K
8-K 2021-01-13 2021-01-14 8-K
8-K 2021-01-13 2021-01-13 8-K
8-K 2020-12-22 2020-12-23 8-K
10-Q 2020-09-30 2020-11-10 10-Q
8-K 2020-11-10 2020-11-10 8-K
8-K 2020-10-26 2020-10-26 8-K
8-K 2020-08-27 2020-09-02 8-K
8-K 2020-08-25 2020-08-25 8-K
10-Q 2020-06-30 2020-08-06 10-Q
8-K 2020-08-06 2020-08-06 8-K
8-K 2020-07-15 2020-07-15 8-K
8-K 2020-07-08 2020-07-08 8-K
8-K 2020-06-19 2020-06-19 8-K
8-K 2020-05-27 2020-05-28 8-K
8-K 2020-05-20 2020-05-20 8-K
8-K 2020-05-12 2020-05-12 8-K
10-Q 2020-03-31 2020-05-12 10-Q
10-K 2019-12-31 2020-03-12 10-K
8-K 2020-03-12 2020-03-12 8-K
8-K 2020-01-27 2020-01-27 8-K
8-K 2020-01-21 2020-01-23 8-K
8-K 2020-01-21 2020-01-21 8-K
8-K 2019-12-20 2019-12-20 8-K
8-K 2019-11-29 2019-12-02 8-K
8-K 2019-11-12 2019-11-13 8-K-NASDAQ EXTENSION
10-Q 2019-09-30 2019-11-07 10-Q
8-K 2019-11-07 2019-11-07 8-K
8-K 2019-09-17 2019-09-17 8-K
10-Q 2019-06-30 2019-08-08 10-Q
8-K 2019-08-08 2019-08-08 8-K
8-K 2019-06-26 2019-06-27 8-K
8-K 2019-06-17 2019-06-19 8-K
8-K 2019-05-15 2019-05-17 8-K
10-Q 2019-03-31 2019-05-08 10-Q1-2019
8-K 2019-05-08 2019-05-08 8-K - Q1 EARNINGS
8-K 2019-05-02 2019-05-03 8-K
8-K 2019-04-02 2019-04-02 8-K
8-K 2019-03-14 2019-03-14 8-K
10-K 2018-12-31 2019-03-06 10-K
8-K 2019-03-06 2019-03-06 8-K
8-K 2019-03-04 2019-03-04 8-K
8-K 2019-01-05 2019-01-07 8-K
10-Q 2018-09-30 2018-11-13 10-Q
8-K 2018-11-13 2018-11-13 8-K
8-K 2018-08-16 2018-08-16 8-K
10-Q 2018-06-30 2018-08-09 10-Q
8-K 2018-08-09 2018-08-09 8-K - Q2
8-K 2018-06-04 2018-06-04 8-K
10-Q 2018-03-31 2018-05-14 10-Q1
8-K 2018-05-14 2018-05-14 8-K - Q1 EARNINGS
8-K 2018-05-09 2018-05-10 8-K - MEXICAN PATENT
8-K 2018-04-30 2018-04-30 8-K - EUROPEAN PATENT
8-K 2018-04-26 2018-04-27 8-K - ANNUAL MEETING RESULTS 2018
8-K 2018-03-29 2018-04-04 8-K
8-K 2018-03-21 2018-03-26 8-K - MALLINCKRODT
8-K 2018-03-22 2018-03-23 8-K
10-K 2017-12-31 2018-03-07 10-K-2017
8-K 2018-03-07 2018-03-07 8-K
8-K 2018-03-05 2018-03-05 8-K
8-K 2018-02-15 2018-02-15 8-K - PR - FDA
8-K 2017-11-14 2017-11-14 8-K Q3 EARNINGS RELEASE
10-Q 2017-09-30 2017-11-14 10-Q3
8-K 2017-11-07 2017-11-09 8-K - COMMERCIAL MANUFACTURING
8-K 2017-10-23 2017-10-23 8-K - POSITIVE RESULTS
8-K 2017-09-12 2017-09-12 8-K
10-Q 2017-06-30 2017-08-14 10-Q
8-K 2017-08-14 2017-08-14 8-K
8-K 2017-08-14 2017-08-14 8-K-DOSING
8-K 2017-05-15 2017-05-15 8-K
10-Q 2017-03-31 2017-05-15 10-Q
8-K 2017-05-10 2017-05-10 8-K - DDW
8-K 2017-05-03 2017-05-04 8-K
8-K 2017-04-18 2017-04-18 8-K
8-K 2017-04-04 2017-04-04 8-K - PK PROTOCOL
8-K 2017-03-21 2017-03-21 8-K
10-K 2016-12-31 2017-03-15 EVOK-10K-20161231
8-K 2017-03-15 2017-03-15 8-K
8-K 2017-03-10 2017-03-10 8-K
8-K 2017-02-15 2017-02-16 8-K
8-K 2017-02-15 2017-02-15 8-K
8-K 2017-01-09 2017-01-09 8-K
8-K 2017-01-04 2017-01-04 8-K
8-K 2016-12-19 2016-12-21 8-K
8-K 2016-12-15 2016-12-16 8-K
8-K 2016-12-15 2016-12-15 8-K
8-K 2016-11-09 2016-11-09 8-K
10-Q 2016-09-30 2016-11-09 10-Q
8-K 2016-09-07 2016-09-07 FORM 8-K
8-K 2016-08-15 2016-08-15 8-K
10-Q 2016-06-30 2016-08-15 10-Q
8-K 2016-08-04 2016-08-08 8-K
8-K 2016-07-29 2016-08-01 8-K
8-K 2016-07-19 2016-07-20 FORM 8-K
8-K 2016-07-18 2016-07-18 8-K
8-K 2016-07-06 2016-07-07 8-K - INVENTIVE
8-K 2016-06-01 2016-06-02 8-K
8-K 2016-05-16 2016-05-19 8-K
8-K 2016-05-11 2016-05-11 8-K
10-Q 2016-03-31 2016-05-11 10-Q
8-K 2016-05-03 2016-05-03 8-K
8-K 2016-04-27 2016-04-28 8-K
8-K 2016-04-25 2016-04-25 8-K
8-K 2016-04-15 2016-04-15 8-K
8-K 2016-03-10 2016-03-10 8-K
10-K 2015-12-31 2016-03-10 10-K
8-K 2016-02-29 2016-03-01 8-K
8-K 2015-11-12 2015-11-12 8-K
10-Q 2015-09-30 2015-11-12 10-Q
8-K 2015-10-06 2015-10-07 8-K
8-K 2015-09-28 2015-09-28 8-K
8-K 2015-09-15 2015-09-16 8-K
8-K 2015-08-18 2015-08-18 8-K
8-K 2015-08-13 2015-08-13 8-K
10-Q 2015-06-30 2015-08-13 10-Q
8-K 2015-05-14 2015-05-14 8-K
10-Q 2015-03-31 2015-05-14 10-Q
8-K 2015-04-22 2015-04-23 8-K
8-K 2015-04-14 2015-04-14 8-K
8-K 2015-04-09 2015-04-09 8-K
8-K 2015-03-11 2015-03-11 8-K
8-K 2015-03-04 2015-03-04 8-K
10-K 2014-12-31 2015-03-04 10-K
8-K 2015-02-02 2015-02-02 8-K
8-K 2015-01-21 2015-01-22 8-K
8-K 2014-12-31 2015-01-06 8-K
8-K 2014-11-25 2014-12-02 FORM 8-K
8-K 2014-12-02 2014-12-02 FORM 8-K
10-Q 2014-09-30 2014-11-13 10-Q
10-Q 2014-06-30 2014-08-13 10-Q
8-K 2014-05-23 2014-05-28 FORM 8-K
8-K 2014-05-21 2014-05-21 FORM 8-K
10-Q 2014-03-31 2014-05-13 FORM 10-Q
8-K 2014-05-13 2014-05-13 FORM 8-K
10-K 2013-12-31 2014-03-25 10-K
8-K 2014-03-25 2014-03-25 FORM 8-K
8-K 2014-02-06 2014-02-07 FORM 8-K
8-K 2014-01-29 2014-01-31 FORM 8-K
8-K 2013-12-01 2013-12-02 FORM 8-K
8-K 2013-11-25 2013-12-02 FORM 8-K
10-Q 2013-09-30 2013-11-13 FORM 10-Q
8-K 2013-11-13 2013-11-13 FORM 8-K
8-K 2013-10-08 2013-10-08 FORM 8-K
8-K 2013-09-30 2013-09-30 8-K